CIDeRplusGeneral Information:
| Id: | 3,562 (click here to show other Interactions for entry) |
| Diseases: |
Diabetes mellitus, type II
- [OMIM]
Insulin resistance |
| Homo sapiens | |
| article | |
| Reference: | Bao Y et al.(2009) Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers J. Proteome Res. 8: 1623-1630 [PMID: 19714868] |
Interaction Information:
| Comment | All of the three treatments were able to down-regulate the high level of glutamate to a lower level in serum, suggesting a possible effect on prevention and amelioration of diabetic complications in T2DM patients, since it has been reported that a high level of serum glutamate is involved in immunodeficiency, amyotrophic lateral sclerosis, and neurological complications. |
|
Formal Description Interaction-ID: 33211 |
drug/chemical compound decreases_quantity of drug/chemical compound |
| Drugbank entries | Show/Hide entries for Repaglinide |